The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2019 | Genome sequencing as a prognostic tool
Richard Rosenquist, MD, PhD, Karolinska University Hospital, Solna, Sweden, discusses the role of genomics as a prognostic and predictive tool in cancer treatment and outlines some of the techniques currently employed. This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.
